These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 32284036)

  • 41. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Screening of Clinical Multidrug-Resistant Gram-Negative Bacteria Shows Endemicity of Carbapenemases, Coexistence of Multiple Carbapenemases, and Rarity of
    Mmatli M; Leshaba TMS; Skosana LB; Mbelle NM; Osei Sekyere J
    Microb Drug Resist; 2022 Nov; 28(11):1028-1036. PubMed ID: 36251876
    [No Abstract]   [Full Text] [Related]  

  • 43. Colistin and polymyxin B in critical care.
    Michalopoulos A; Falagas ME
    Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria.
    Falagas ME; Bliziotis IA; Kasiakou SK; Samonis G; Athanassopoulou P; Michalopoulos A
    BMC Infect Dis; 2005 Apr; 5():24. PubMed ID: 15819983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resurgence of colistin use.
    Sarkar S; DeSantis ER; Kuper J
    Am J Health Syst Pharm; 2007 Dec; 64(23):2462-6. PubMed ID: 18029951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colistin: re-emergence of the 'forgotten' antimicrobial agent.
    Dhariwal AK; Tullu MS
    J Postgrad Med; 2013; 59(3):208-15. PubMed ID: 24029199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomes.
    Kaundal S; Jandial A; Singh H; Chopra M; Kasudhan KS; Khaire N; Khadwal A; Prakash G; Jain A; Suri V; Patil A; Arora A; Sharma V; Ray P; Malhotra P; Lad DP
    Transpl Infect Dis; 2021 Oct; 23(5):e13717. PubMed ID: 34431187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
    Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
    Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colistin for the treatment of multidrug-resistant infections.
    LaPlante K; Cusumano J; Tillotson G
    Lancet Infect Dis; 2018 Nov; 18(11):1174-1175. PubMed ID: 30507395
    [No Abstract]   [Full Text] [Related]  

  • 53. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
    Int J Antimicrob Agents; 2021 May; 57(5):106344. PubMed ID: 33857539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance cultures for detection of rectal and lower respiratory tract carriage of colistin-resistant Gram-negative bacilli in intensive care unit patients: comparison of direct plating and pre-enrichment step.
    Germ J; Cerar Kišek T; Kokošar Ulčar B; Lejko Zupanc T; Mrvič T; Kerin Povšič M; Seme K; Pirs M
    J Med Microbiol; 2019 Sep; 68(9):1269-1278. PubMed ID: 31237536
    [No Abstract]   [Full Text] [Related]  

  • 56. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colistin: new lessons on an old antibiotic.
    Yahav D; Farbman L; Leibovici L; Paul M
    Clin Microbiol Infect; 2012 Jan; 18(1):18-29. PubMed ID: 22168320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.
    Chien HT; Lin YC; Sheu CC; Hsieh KP; Chang JS
    Int J Antimicrob Agents; 2020 Mar; 55(3):105889. PubMed ID: 31923573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.